-   directed: true
    graph:
        disease: Acute coronary syndrome
        disease_mesh: MESH:D054058
        drug: eptifibatide
        drug_mesh: MESH:C086648
        drugbank: DB:DB00063
    links:
    -   key: decreases activity of
        source: MESH:C086648
        target: UniProt:P05106
    -   key: decreases activity of
        source: MESH:C086648
        target: UniProt:P08514
    -   key: positively regulates
        source: UniProt:P05106
        target: GO:0070527
    -   key: positively regulates
        source: UniProt:P08514
        target: GO:0070527
    -   key: positively correlated with
        source: GO:0070527
        target: GO:0072378
    -   key: negatively regulates
        source: GO:0072378
        target: GO:0008015
    -   key:  negatively correlated with
        source: GO:0008015
        target: MESH:D054058
    multigraph: true
    nodes:
    -   id: MESH:C086648
        label: Drug
        name: Eptifibatide
    -   id: UniProt:P05106
        label: Protein
        name: Integrin beta-3
    -   id: UniProt:P08514
        label: Protein
        name: Integrin alpha-IIb
    -   id: GO:0072378
        label: BiologicalProcess
        name: Blood coagulation, fibrin clot formation
    -   id: GO:0008015
        label: BiologicalProcess
        name: Blood circulation
    -   id: GO:0070527
        label: BiologicalProcess
        name: Platelet aggregation
    -   id: MESH:D054058
        label: Disease
        name: Acute coronary syndrome
    reference: https://go.drugbank.com/drugs/DB00063 https://en.wikipedia.org/wiki/Eptifibatide
-   directed: true
    graph:
        disease: Peptic ulcer
        disease_mesh: MESH:D010437
        drug: Pantoprazole
        drug_mesh: MESH:C064276
        drugbank: DB:DB00213
    links:
    -   key: decreases activity of
        source: MESH:C064276
        target: UniProt:P20648
    -   key: positively regulates
        source: UniProt:P20648
        target: GO:0001696
    -   key: increases abundance of
        source: GO:0001696
        target: MESH:D005744
    -   key: positively correlated with
        source: MESH:D005744
        target: MESH:D010437
    multigraph: true
    nodes:
    -   id: MESH:C064276
        label: Drug
        name: Pantoprazole
    -   id: UniProt:P20648
        label: Protein
        name: Potassium-transporting ATPase alpha chain 1
    -   id: GO:0001696
        label: BiologicalProcess
        name: Gastric acid secretion
    -   id: MESH:D005744
        label: ChemicalSubstance
        name: Gastric Acid
    -   id: MESH:D010437
        label: Disease
        name: Peptic ulcer
    reference: https://go.drugbank.com/drugs/DB00213#BE0000349
-   directed: true
    graph:
        disease: Zollinger-Ellison syndrome
        disease_mesh: MESH:D015043
        drug: Pantoprazole
        drug_mesh: MESH:C064276
        drugbank: DB:DB00213
    links:
    -   key: decreases activity of
        source: MESH:C064276
        target: UniProt:P20648
    -   key: positively regulates
        source: UniProt:P20648
        target: GO:0001696
    -   key: increases abundance of
        source: GO:0001696
        target: MESH:D005744
    -   key: positively correlated with
        source: MESH:D005744
        target: MESH:D010437
    -   key: manifestation of
        source: MESH:D010437
        target: MESH:D015043
    multigraph: true
    nodes:
    -   id: MESH:C064276
        label: Drug
        name: Pantoprazole
    -   id: UniProt:P20648
        label: Protein
        name: Potassium-transporting ATPase alpha chain 1
    -   id: GO:0001696
        label: BiologicalProcess
        name: Gastric acid secretion
    -   id: MESH:D005744
        label: ChemicalSubstance
        name: Gastric Acid
    -   id: MESH:D010437
        label: Disease
        name: Peptic ulcer
    -   id: MESH:D015043
        label: Disease
        name: Zollinger-Ellison syndrome
    reference: https://go.drugbank.com/drugs/DB00213#BE0000349 https://en.wikipedia.org/wiki/Zollinger%E2%80%93Ellison_syndrome
-   directed: true
    graph:
        disease: Gastroesophageal reflux disease
        disease_mesh: MESH:D005764
        drug: Pantoprazole
        drug_mesh: MESH:C064276
        drugbank: DB:DB00213
    links:
    -   key: decreases activity of
        source: MESH:C064276
        target: UniProt:P20648
    -   key: positively regulates
        source: UniProt:P20648
        target: GO:0001696
    -   key: increases abundance of
        source: GO:0001696
        target: MESH:D005744
    -   key: positively correlated with
        source: MESH:D005744
        target: MESH:D005764
    multigraph: true
    nodes:
    -   id: MESH:C064276
        label: Drug
        name: Pantoprazole
    -   id: UniProt:P20648
        label: Protein
        name: Potassium-transporting ATPase alpha chain 1
    -   id: GO:0001696
        label: BiologicalProcess
        name: Gastric acid secretion
    -   id: MESH:D005744
        label: ChemicalSubstance
        name: Gastric Acid
    -   id: MESH:D005764
        label: Disease
        name: Gastroesophageal reflux disease
    reference: https://go.drugbank.com/drugs/DB00213#BE0000349 https://en.wikipedia.org/wiki/Zollinger%E2%80%93Ellison_syndrome
-   directed: true
    graph:
        disease: Multiple endocrine adenomas
        disease_mesh: MESH:D009377
        drug: Pantoprazole
        drug_mesh: MESH:C064276
        drugbank: DB:DB00213
    links:
    -   key: decreases activity of
        source: MESH:C064276
        target: UniProt:P20648
    -   key: positively regulates
        source: UniProt:P20648
        target: GO:0001696
    -   key: increases abundance of
        source: GO:0001696
        target: MESH:D005744
    -   key: positively correlated with
        source: MESH:D005744
        target: MESH:D010437
    -   key: manifestation of
        source: MESH:D010437
        target: MESH:D009377
    multigraph: true
    nodes:
    -   id: MESH:C064276
        label: Drug
        name: Pantoprazole
    -   id: UniProt:P20648
        label: Protein
        name: Potassium-transporting ATPase alpha chain 1
    -   id: GO:0001696
        label: BiologicalProcess
        name: Gastric acid secretion
    -   id: MESH:D005744
        label: ChemicalSubstance
        name: Gastric Acid
    -   id: MESH:D010437
        label: Disease
        name: Peptic ulcer
    -   id: MESH:D009377
        label: Disease
        name: Multiple endocrine adenomas
    reference: https://go.drugbank.com/drugs/DB00213#BE0000349
-   directed: true
    graph:
        disease: Non-small cell lung cancer
        disease_mesh: MESH:D002289
        drug: gefitinib
        drug_mesh: MESH:C419708
        drugbank: DB:DB00317
    links:
    -   key: decreases activity of
        source: MESH:C419708
        target: UniProt:P00533
    -   key: positively regulates
        source: UniProt:P00533
        target: REACT:R-HSA-5673001
    -   key: positively regulates
        source: UniProt:P00533
        target: REACT:R-HSA-109704
    -   key: positively regulates
        source: REACT:R-HSA-5673001
        target: GO:0008283
    -   key: positively regulates
        source: REACT:R-HSA-109704
        target: GO:0008283
    -   key: causes
        source: GO:0008283
        target: MESH:D002289
    multigraph: true
    nodes:
    -   id: MESH:C419708
        label: Drug
        name: Gefitinib
    -   id: UniProt:P00533
        label: Protein
        name: Epidermal growth factor receptor
    -   id: REACT:R-HSA-5673001
        label: Pathway
        name: RAF/MAP kinase cascade
    -   id: REACT:R-HSA-109704
        label: Pathway
        name: PI3K Cascade
    -   id: GO:0008283
        label: BiologicalProcess
        name: Cell proliferation
    -   id: MESH:D002289
        label: Disease
        name: Non-small cell lung cancer
    reference: https://go.drugbank.com/drugs/DB00317
-   comment:  Lisuride is used to prevent migraine attacks in low doses. Due to its highly non-selective pharmacological activity, lisuride is described as a "dirty drug".
     The exact mechanism of action of lisuride is not clear however it is likely due to agonism of 5-HT1B/1D receptors.
    directed: true
    graph:
        disease: Migraine
        disease_mesh: MESH:D008881
        drug: Lisuride
        drug_mesh: MESH:D008090
        drugbank: DB:DB00589
    links:
    -   key: positively regulates
        source: MESH:D008090
        target: UniProt:P28222
    -   key: positively regulates
        source: MESH:D008090
        target: UniProt:P28221
    -   key: positively regulates
        source: UniProt:P28222
        target: GO:0004993
    -   key: positively regulates
        source: UniProt:P28221
        target: GO:0004993
    -   key: positively correlated with
        source: GO:0004993
        target: GO:0042310
    -   key: negatively correlated with
        source: GO:0042310
        target: MESH:D008881
    multigraph: true
    nodes:
    -   id: MESH:D008090
        label: Drug
        name: Lisuride
    -   id: UniProt:P28222
        label: Protein
        name: 5-hydroxytryptamine receptor 1B
    -   id: UniProt:P28221
        label: Protein
        name: 5-hydroxytryptamine receptor 1D
    -   id: GO:0004993
        label: MolecularActivity
        name: G protein-coupled serotonin receptor activity
    -   id: GO:0042310
        label: BiologicalProcess
        name: Vasoconstriction
    -   id: MESH:D008881
        label: Disease
        name: Migraine
    reference: https://go.drugbank.com/drugs/DB00589 https://pubmed.ncbi.nlm.nih.gov/10563226/ https://pubmed.ncbi.nlm.nih.gov/16099727/
-   comment: Lisuride is used to treat hyperprolactinemic amenorrhea.
    directed: true
    graph:
        disease: Amenorrhea
        disease_mesh: MESH:D000568
        drug: Lisuride
        drug_mesh: MESH:D008090
        drugbank: DB:DB00589
    links:
    -   key: increases activity of
        source: MESH:D008090
        target: UniProt:P14416
    -   key: participates in
        source: UniProt:P14416
        target: GO:0007195
    -   key: decreases abundance of
        source: GO:0007195
        target: CHEBI:17489
    -   key: positively regulates
        source: CHEBI:17489
        target: GO:0051209
    -   key: contributes to
        source: GO:0051209
        target: GO:1902722
    -   key: causes
        source: GO:1902722
        target: MESH:D006966
    -   key: causes
        source: MESH:D006966
        target: MESH:D000568
    multigraph: true
    nodes:
    -   id: MESH:D008090
        label: Drug
        name: Lisuride
    -   id: UniProt:P14416
        label: Protein
        name: D2 dopamine receptor
    -   id: GO:0007195
        label: BiologicalProcess
        name: Adenylate cyclase-inhibiting dopamine receptor signaling pathway
    -   id: CHEBI:17489
        label: ChemicalSubstance
        name: 3',5'-cyclic AMP
    -   id: GO:0051209
        label: BiologicalProcess
        name: Release of sequestered calcium ion into cytosol
    -   id: GO:1902722
        label: BiologicalProcess
        name: Positive regulation of prolactin secretion
    -   id: MESH:D006966
        label: Disease
        name: Hyperprolactinemia
    -   id: MESH:D000568
        label: Disease
        name: Amenorrhea
    reference: https://go.drugbank.com/drugs/DB00589
-   directed: true
    graph:
        disease: Acromegaly
        disease_mesh: MESH:D000172
        drug: Lisuride
        drug_mesh: MESH:D008090
        drugbank: DB:DB00589
    links:
    -   key: increases activity of
        source: MESH:D008090
        target: UniProt:P14416
    -   key: participates in
        source: UniProt:P14416
        target: GO:0007195 
    -   key: negatively regulates
        source: GO:0007195
        target: GO:0030252
    -   key: increases abundance of
        source: GO:0030252
        target: MESH:D013006
    -   key: causes
        source: MESH:D013006
        target: MESH:D000172
    multigraph: true
    nodes:
    -   id: MESH:D008090
        label: Drug
        name: Lisuride
    -   id: UniProt:P14416
        label: Protein
        name: D2 dopamine receptor
    -   id: GO:0007195
        label: BiologicalProcess
        name: Adenylate cyclase-inhibiting dopamine receptor signaling pathway
    -   id: GO:0030252
        label: BiologicalProcess
        name: Growth hormone secretion
    -   id: MESH:D013006
        label: ChemicalSubstance
        name: Growth Hormone
    -   id: MESH:D000172
        label: Disease
        name: Acromegaly
    reference: https://go.drugbank.com/drugs/DB00589 https://link.springer.com/article/10.1007/s11102-016-0778-2
-   directed: true
    graph:
        disease: Hypertensive disorder
        disease_mesh: MESH:D006973
        drug: Eprosartan
        drug_mesh: MESH:C068373
        drugbank: DB:DB00876
    links:
    -   key: negatively regulates
        source: MESH:C068373
        target: UniProt:P30556
    -   key: positively correlated with
        source: UniProt:P30556
        target: MESH:D000804
    -   key: positively regulates
        source: MESH:D000804
        target: MESH:D014661
    -   key: positively correlated with
        source: MESH:D014661
        target: GO:0008217
    -   key: positively correlated with
        source: GO:0008217
        target: MESH:D006973
    multigraph: true
    nodes:
    -   id: MESH:C068373
        label: Drug
        name: Eprosartan
    -   id: UniProt:P30556
        label: Protein
        name: Type-1 angiotensin II receptor
    -   id: MESH:D000804
        label: ChemicalSubstance
        name: Angiotensin II
    -   id: MESH:D014661
        label: Disease
        name: Vasoconstriction
    -   id: GO:0008217
        label: BiologicalProcess
        name: Blood pressure
    -   id: MESH:D006973
        label: Disease
        name: Hypertensive disorder
    reference: https://go.drugbank.com/drugs/DB00876
-   comment: Levosimendan has not been approved for use in the U.S. or Canada.  It has been reported that levosimendan may act preferentially as a Ca2+ sensitizer at lower concentrations.
    directed: true
    graph:
        disease: Congestive heart failure
        disease_mesh: MESH:D006333
        drug: levosimendan
        drug_mesh: MESH:C076731
        drugbank: DB:DB00922
    links:
    -   key: increases stability of
        source: MESH:C076731
        target: UniProt:P63316
    -   key: positively regulates
        source: UniProt:P63316
        target: GO:0060047
    -   key: negatively correlated with
        source: GO:0060047
        target: MESH:D006333
    -   key: increases activity of
        source: MESH:C076731
        target: UniProt:Q14654
    -   key: increases activity of
        source: MESH:C076731
        target: UniProt:Q15842
    -   key: positively regulates
        source: UniProt:Q14654
        target: GO:0044557
    -   key: positively regulates
        source: UniProt:Q15842
        target: GO:0044557
    -   key: positively regulates
        source: GO:0044557
        target: GO:0042311
    -   key: negatively correlated with
        source: GO:0042311
        target: HP:0000822
    -   key: affects risk for
        source: HP:0000822
        target: MESH:D006333
    multigraph: true
    nodes:
    -   id: MESH:C076731
        label: Drug
        name: Levosimendan
    -   id: UniProt:P63316
        label: Protein
        name: Troponin C, slow skeletal and cardiac muscles
    -   id: GO:0060047
        label: BiologicalProcess
        name: Heart contraction
    -   id: UniProt:Q15842
        label: Protein
        name: ATP-sensitive inward rectifier potassium channel 8 
    -   id: UniProt:Q14654
        label: Protein
        name: ATP-sensitive inward rectifier potassium channel 11
    -   id: GO:0044557
        label: BiologicalProcess
        name: Relaxation of smooth muscle
    -   id: GO:0042311
        label: BiologicalProcess
        name: Vasodilation
    -   id: HP:0000822
        label: PhenotypicFeature
        name: Hypertension
    -   id: MESH:D006333
        label: Disease
        name: Congestive heart failure
    reference: https://go.drugbank.com/drugs/DB00922
-   comment: Levosimendan has not been approved for use in the U.S. or Canada.  It has been reported that levosimendan may act preferentially as a Ca2+ sensitizer at lower concentrations,
       whereas at higher concentrations its action as a PDE-III inhibitor becomes more prominent in experimental animals and humans.
    directed: true
    graph:
        disease: Congestive heart failure
        disease_mesh: MESH:D006333
        drug: levosimendan
        drug_mesh: MESH:C076731
        drugbank: DB:DB00922
    links:
    -   key: decreases activity of
        source: MESH:C076731
        target: UniProt:Q14432
    -   key: decreases abundance of
        source: UniProt:Q14432
        target: CHEBI:17489
    -   key: positively regulates
        source: CHEBI:17489
        target: GO:0004679
    -   key: positively regulates
        source: GO:0004679
        target: GO:0005262
    -   key: positively regulates
        source: GO:0005262
        target: GO:0070509
    -   key: positively regulates
        source: GO:0070509
        target: GO:0060047
    -   key: negatively correlated with
        source: GO:0060047
        target: MESH:D006333
    -   key: positively regulates
        source: CHEBI:17489
        target: GO:0044557 
    -   key: positively regulates
        source: GO:0044557
        target: GO:0042311
    -   key: negatively correlated with
        source: GO:0042311
        target: HP:0000822
    -   key: affects risk for
        source: HP:0000822
        target: MESH:D006333
    multigraph: true
    nodes:
    -   id: MESH:C076731
        label: Drug
        name: Levosimendan
    -   id: UniProt:Q14432
        label: Protein
        name: cGMP-inhibited 3',5'-cyclic phosphodiesterase A
    -   id: CHEBI:17489
        label: ChemicalSubstance
        name:  3',5'-cyclic AMP
    -   id: GO:0004679
        label: MolecularActivity
        name: AMP-activated protein kinase activity
    -   id: GO:0005262
        label: MolecularActivity
        name: Calcium channel activity
    -   id: GO:0070509
        label: BiologicalProcess
        name: Calcium ion import
    -   id: GO:0060047
        label: BiologicalProcess
        name: Heart contraction
    -   id: GO:0044557
        label: BiologicalProcess
        name: Relaxation of smooth muscle
    -   id: GO:0042311
        label: BiologicalProcess
        name: Vasodilation
    -   id: HP:0000822
        label: PhenotypicFeature
        name: Hypertension
    -   id: MESH:D006333
        label: Disease
        name: Congestive heart failure 
    reference: https://go.drugbank.com/drugs/DB00922
-   directed: true
    graph:
        disease: Non-small cell lung cancer
        disease_mesh: MESH:D002289
        drug: pemetrexed
        drug_mesh: MESH:D000068437
        drugbank: DB:DB00642
    links:
    -   key: decreases activity of
        source: MESH:D000068437
        target: UniProt:P04818
    -   key: decreases activity of
        source: MESH:D000068437
        target: UniProt:P00374
    -   key: decreases activity of
        source: MESH:D000068437
        target: UniProt:P22102
    -   key: participates in
        source: UniProt:P04818
        target: GO:0046105
    -   key: participates in
        source: UniProt:P00374
        target: GO:0046105
    -   key: participates in
        source: UniProt:P22102
        target: GO:0046105
    -   key: precedes
        source: GO:0046105
        target: GO:0071897
    -   key: decreases activity of
        source: MESH:D000068437
        target: UniProt:P31939
    -   key: participates in
        source: UniProt:P31939
        target: GO:0042451
    -   key:  precedes
        source: GO:0042451
        target: GO:0032774
    -   key: part of
        source: GO:0032774
        target: GO:0008283
    -   key: part of
        source: GO:0071897
        target: GO:0008283
    -   key: positively correlated with
        source: GO:0008283
        target: MESH:D002289
    multigraph: true
    nodes:
    -   id: MESH:D000068437
        label: Drug
        name: Pemetrexed
    -   id: UniProt:P04818
        label: Protein
        name: Thymidylate synthase
    -   id: UniProt:P00374
        label: Protein
        name: Dihydrofolate reductase
    -   id: UniProt:P22102
        label: Protein
        name: Trifunctional purine biosynthetic protein adenosine-3
    -   id: GO:0046105
        label: BiologicalProcess
        name: Thymidine biosynthetic process
    -   id: UniProt:P31939
        label: Protein
        name: Bifunctional purine biosynthesis protein ATIC
    -   id: GO:0042451
        label: BiologicalProcess
        name: Purine nucleoside biosynthetic process
    -   id: GO:0071897
        label: BiologicalProcess 
        name: DNA biosynthetic process
    -   id: GO:0032774
        label: BiologicalProcess
        name: RNA biosynthetic process
    -   id: GO:0008283
        label: BiologicalProcess
        name: Cell population proliferation
    -   id: MESH:D002289
        label: Disease
        name: Non-small cell lung cancer
    reference: https://go.drugbank.com/drugs/DB00642#BE0001240 https://en.wikipedia.org/wiki/Pemetrexed#Mechanism_of_action
-   directed: true
    graph:
        disease: Angiofollicular lymph node hyperplasia
        disease_mesh: MESH:D005871
        drug: tocilizumab
        drug_mesh: MESH:C502936
        drugbank: DB:DB06273
    links:
    -   key: decreases activity of
        source: MESH:C502936
        target: UniProt:P08887
    -   key: positively regulates
        source: UniProt:P08887
        target: GO:0070741
    -   key: positively regulates
        source: GO:0070741
        target: GO:0006954
    -   key: occurs in
        source: GO:0006954
        target: MESH:D005871
    multigraph: true
    nodes:
    -   id: MESH:C502936
        label: Drug
        name: Tocilizumab
    -   id: UniProt:P08887
        label: Protein
        name: Interleukin-6 receptor subunit alpha
    -   id: GO:0070741
        label: BiologicalProcess
        name: Response to interleukin-6
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammatory response
    -   id: MESH:D005871
        label: Drug
        name: Angiofollicular lymph node hyperplasia
    reference: https://go.drugbank.com/drugs/DB06273
-   directed: true
    graph:
        disease: Giant cell arteritis
        disease_mesh: MESH:D013700
        drug: tocilizumab
        drug_mesh: MESH:C502936
        drugbank: DB:DB06273
    links:
    -   key: decreases activity of
        source: MESH:C502936
        target: UniProt:P08887
    -   key: positively regulates
        source: UniProt:P08887
        target: GO:0070741
    -   key: positively regulates
        source: GO:0070741
        target: GO:0006954
    -   key: occurs in
        source: GO:0006954
        target: MESH:D013700
    multigraph: true
    nodes:
    -   id: MESH:C502936
        label: Drug
        name: Tocilizumab
    -   id: UniProt:P08887
        label: Protein
        name: Interleukin-6 receptor subunit alpha
    -   id: GO:0070741
        label: BiologicalProcess
        name: Response to interleukin-6
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammatory response
    -   id: MESH:D013700
        label: Drug
        name: Giant cell arteritis
    reference: https://go.drugbank.com/drugs/DB06273
-   directed: true
    graph:
        disease: Rheumatoid arthritis
        disease_mesh: MESH:D001172
        drug: tocilizumab
        drug_mesh: MESH:C502936
        drugbank: DB:DB06273
    links:
    -   key: decreases activity of
        source: MESH:C502936
        target: UniProt:P08887
    -   key: positively regulates
        source: UniProt:P08887
        target: GO:0070741
    -   key: positively regulates
        source: GO:0070741
        target: GO:0006954
    -   key: occurs in
        source: GO:0006954
        target: MESH:D001172
    multigraph: true
    nodes:
    -   id: MESH:C502936
        label: Drug
        name: Tocilizumab
    -   id: UniProt:P08887
        label: Protein
        name: Interleukin-6 receptor subunit alpha
    -   id: GO:0070741
        label: BiologicalProcess
        name: Response to interleukin-6
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammatory response
    -   id: MESH:D001172
        label: Drug
        name: Rheumatoid arthritis
    reference: https://go.drugbank.com/drugs/DB06273
-   directed: true
    graph:
        disease: Juvenile rheumatoid arthritis
        disease_mesh: MESH:D001171
        drug: tocilizumab
        drug_mesh: MESH:C502936
        drugbank: DB:DB06273
    links:
    -   key: decreases activity of
        source: MESH:C502936
        target: UniProt:P08887
    -   key: positively regulates
        source: UniProt:P08887
        target: GO:0070741
    -   key: positively regulates
        source: GO:0070741
        target: GO:0006954
    -   key: occurs in
        source: GO:0006954
        target: MESH:D001171
    multigraph: true
    nodes:
    -   id: MESH:C502936
        label: Drug
        name: Tocilizumab
    -   id: UniProt:P08887
        label: Protein
        name: Interleukin-6 receptor subunit alpha
    -   id: GO:0070741
        label: BiologicalProcess
        name: Response to interleukin-6
    -   id: GO:0006954
        label: BiologicalProcess
        name: Inflammatory response
    -   id: MESH:D001171
        label: Drug
        name: Juvenile rheumatoid arthritis
    reference: https://go.drugbank.com/drugs/DB06273
-   directed: true
    graph:
        disease: Parkinson's disease
        disease_mesh: MESH:D010300
        drug: safinamide
        drug_mesh: MESH:C092797
        drugbank: DB:DB06654
    links:
    -   key: decreases activity of
        source: MESH:C092797
        target: UniProt:P27338
    -   key: decreases abundance of
        source: UniProt:P27338
        target: MESH:D004298
    -   key: participates in
        source: MESH:D004298
        target: GO:0061527
    -   key: disrupted by
        source: GO:0061527
        target: MESH:D010300
    multigraph: true
    nodes:
    -   id: MESH:C092797
        label: Drug
        name: Safinamide
    -   id: UniProt:P27338
        label: Protein
        name: Amine oxidase [flavin-containing] B
    -   id: MESH:D004298
        label: ChemicalSubstance
        name: Dopamine
    -   id: GO:0061527
        label: BiologicalProcess
        name: Dopamine secretion, neurotransmission
    -   id: MESH:D010300
        label: Disease
        name: Parkinson's disease
    reference: https://go.drugbank.com/drugs/DB06654
-   comment: The presence of deuterium in deutetrabenazine increases the half-lives of the active metabolite and prolongs
     their pharmacological activity by attenuating CYP2D6 metabolism of the compound.
    directed: true
    graph:
        disease: Tardive dyskinesia
        disease_mesh: MESH:D000071057
        drug: deutetrabenazine
        drug_mesh: MESH:C000609690
        drugbank: DB:DB12161
    links:
    -   key: has metabolite
        source: MESH:C000609690
        target: DB:DB04844
    -   key: decreases activity of
        source: DB:DB04844
        target: UniProt:Q05940
    -   key: positively regulates
        source: UniProt:Q05940
        target: GO:0015842
    -   key: prevents
        source: GO:0015842
        target: GO:0042420
    -   key: negatively regulates
        source: GO:0042420
        target: GO:0061527
    -   key: correlated with
        source: GO:0061527
        target: MESH:D000071057
    multigraph: true
    nodes:
    -   id: DB:DB04844
        label: Drug
        name: Tetrabenazine
    -   id: MESH:C000609690
        label: Drug
        name: Deutetrabenazine
    -   id: UniProt:Q05940 
        label: Protein
        name: Synaptic vesicular amine transporter
    -   id: GO:0015842
        label: BiologicalProcess
        name: Aminergic neurotransmitter loading into synaptic vesicle
    -   id: GO:0042420
        label: BiologicalProcess
        name: Dopamine catabolic process
    -   id: GO:0061527
        label: BiologicalProcess
        name: Dopamine secretion, neurotransmission
    -   id: MESH:D000071057
        label: Disease
        name: Tardive dyskinesia
    reference: https://go.drugbank.com/drugs/DB12161 https://en.wikipedia.org/wiki/Tardive_dyskinesia
         https://en.wikipedia.org/wiki/Tetrabenazine#Pharmacology
-   comment: The presence of deuterium in deutetrabenazine increases the half-lives of the active metabolite and prolongs
     their pharmacological activity by attenuating CYP2D6 metabolism of the compound.
    directed: true
    graph:
        disease: Huntington's chorea
        disease_mesh: MESH:D006816
        drug: deutetrabenazine
        drug_mesh: MESH:C000609690
        drugbank: DB:DB12161
    links:
    -   key: has metabolite
        source: MESH:C000609690
        target: DB:DB04844
    -   key: decreases activity of
        source: DB:DB04844
        target: UniProt:Q05940
    -   key: positively regulates
        source: UniProt:Q05940
        target: GO:0015842
    -   key: prevents
        source: GO:0015842
        target: GO:0042420
    -   key: negatively regulates
        source: GO:0042420
        target: GO:0061527
    -   key: correlated with
        source: GO:0061527
        target: MESH:D006816
    multigraph: true
    nodes:
    -   id: DB:DB04844
        label: Drug
        name: Tetrabenazine
    -   id: MESH:C000609690
        label: Drug
        name: Deutetrabenazine
    -   id: UniProt:Q05940 
        label: Protein
        name: Synaptic vesicular amine transporter
    -   id: GO:0015842
        label: BiologicalProcess
        name: Aminergic neurotransmitter loading into synaptic vesicle
    -   id: GO:0042420
        label: BiologicalProcess
        name: Dopamine catabolic process
    -   id: GO:0061527
        label: BiologicalProcess
        name: Dopamine secretion, neurotransmission
    -   id: MESH:D006816
        label: Disease
        name: Huntington's chorea
    reference: https://go.drugbank.com/drugs/DB12161  https://en.wikipedia.org/wiki/Chorea
         https://en.wikipedia.org/wiki/Tetrabenazine#Pharmacology
-   comment: Higher doses of opipramol are needed for anti-depressant effect.
    directed: true
    graph:
        disease: Depressive disorder
        disease_mesh: MESH:D003866
        drug: opipramol
        drug_mesh: MESH:D009888
        drugbank: DB:DB12930
    links:
    -   key: increases activity of
        source: MESH:D009888
        target: UniProt:Q99720
    -   key: positively regulates
        source: UniProt:Q99720
        target: GO:0007269
    -   key: treats
        source: GO:0007269
        target: MESH:D003866
    multigraph: true
    nodes:
    -   id: MESH:D009888
        label: Drug
        name: Opipramol
    -   id: UniProt:Q99720
        label: Protein
        name: Sigma non-opioid intracellular receptor 1
    -   id: GO:0007269
        label: BiologicalProcess
        name: Neurotransmitter secretion
    -   id: MESH:D003866
        label: Disease
        name: Depressive disorder
    reference: https://en.wikipedia.org/wiki/Opipramol https://pubmed.ncbi.nlm.nih.gov/15547785/
          https://www.researchgate.net/publication/259936188_OPIPRAMOL_A_NOVEL_DRUG
